Boehringer Ingelheim

Boehringer Ingelheim is a leading, research-driven biopharmaceutical company active in both human and animal health. Founded in 1885 and still family-owned today, the company is dedicated to developing innovative therapies and solutions that improve the lives of people and animals around the world. With approximately 54,300 employees serving more than 130 markets, Boehringer Ingelheim is one of the pharmaceutical industry's top investors in research and development. Guided by its purpose of transforming lives for generations, the company focuses on addressing areas of significant unmet medical need while advancing long-term sustainability across its global operations.